Hospital Arnau de Vilanova-Santa María
Lleida, 25198, Spain
NCT Number: NCT02234765
Obstructive sleep apnea syndrome (OSA) is characterized by the manifestation of excessive sleepiness secondary to repeated obstruction of the upper airway during sleep and cognitive-behavioral, respiratory, cardiac, metabolic or inflammatory disorders. Epidemiological studies in our country have shown that OSA is a highly prevalent disease in the general population, affecting 2-4% of the adult population. The most important clinical manifestations of OSAS is a deterioration in the quality of life and an increase in cardiovascular disease. OSA is also associated with traffic accidents. Therefore, and considering the medical complications of OSA, as well as the sociolaboral impact and its negative impact on quality of life and survival; is stated that this disease is a public health problem that requires the physician to identify patients eligible to treatment. Moreover, it has been shown that undiagnosed patients, duplicate the consumption of health resources, comparing when the diagnosis and treatment has been established. Finally, we have a highly effective treatment using positive pressure in the upper airway (CPAP) that has been shown to be effective and cost-effective. The current situation in which all patients diagnosed with OSA and receiving different treatments are monitored and controlled by the Sleep Units (SU) is an oversized medicine specialist at the expense of primary care (PC). Our working hypothesis is: "By the coordination of actions at various levels including interactive training equipment AP, use the bilateral (SU-AP) of electronic medical records and the use of new technologies can be achieved in AP satisfactory management of the diagnostic and therapeutic process of patients with suspected OSA. Patients assisted in both areas have a level of clinical response, satisfaction, compliance and avoidance of complications, similar to that obtained with monitoring by SU. In addition, management by AP will be more cost-effective than in the SU."
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Lleida, 25198, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be diagnosed and follow-up in Primary Care.
Standard management according to Spanish Respiratory Society guidelines in Sleep Unit.
Time frame: baseline and 6 months
Epworth Sleepiness Scale (ESS)
Time frame: 6 months
QUALYS
Time frame: baseline and 6 months
EuroQol (EQ5D)
Time frame: 6 months
Visual analog scale
Time frame: 6 months
Objective data to be downloaded from the CPAP device
Time frame: 6 months
Adverse events / secondary effects related to CPAP compliance.
Time frame: Baseline and 6 months
Office blood pressure
Time frame: Baseline and 6 months
Time frame: 6 months
Sociedad Española de Neumología y Cirugía Torácica
Other
Management of Patients With Suspected Sleep Apnea Syndrome From Primary Care: Territorial Assistance Network.
Acronym: GESAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02893865
Apnea, Arterial Occlusive Diseases
Montpellier, France
View Trial DetailsNCT02906839
Apnea, Arrhythmias, Cardiac
Paris, France
View Trial DetailsNCT02657304
Apnea, Dyssomnias
Saint-Etienne, France
View Trial DetailsNCT02916160
Apnea, Chronic Heart Failure
Bordeaux, Pessac, France
View Trial Details